Vaxil Bio's total assets for Q2 2025 were C$697.00K, an increase of 1.90% from the previous quarter. TSE:VXL total liabilities were C$6.00K for the fiscal quarter, a -85.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.